Catalent Pharma Solutions

Catalent Biologics is a global leader in biopharmaceutical development  services, bringing next-generation therapies to the market. Its recent  acquisitions of Paragon Bioservices and MaSTherCell have expanded  its service portfolio to include development and manufacturing of cell  and gene therapies, alongside new biological entities, biosimilars, sterile injectables, and antibody-drug conjugates.


	14 Schoolhouse Road Somerset, NJ 08873, USA
	

Articles

Catalent Biologics is a global leader in biopharmaceutical development services, bringing next-generation therapies to the market. 

Next-Generation Biopharmaceutical Development Services

Catalent Biologics is a global leader in biopharmaceutical development services, bringing next-generation therapies to the market. Its recent acquisitions of Paragon Bioservices and MaSTherCell have expanded its service portfolio to include development and manufacturing of cell and gene therapies, alongside new biological entities, biosimilars, sterile injectables, and antibody-drug conjugates.


	14 Schoolhouse Road Somerset, NJ 08873, USA
	solutions@ catalent.com
	

Bioassays are critical for assessing potency and biological activity during biopharmaceutical activity, but they must be carefully designed to ensure reliability. Learn about new developments in cell-based bioassays and binding assays.


Frontiers in Binding Assays and Bioassays

	Catalent has over 25 years’ experience in providing comprehensive clinical supply services, and has supported over 5,000 trials globally. Through eight cGMP clinical supply facilities across the U.S., Europe and Asia-Pacific region, and a global network of 50+ depots with a combined capacity of more than 1,400,000 cubic feet of controlled temperature space, Catalent manages more than 150,000 shipments per year to over 80 countries.

	Catalent’s innovative FastChain™ demand led supply solution enables clinical sites to receive patient kits within a matter of days instead of weeks and can reduce clinical waste from more than 200% to less than 20%.

	Catalent offers customers a full range of tailored solutions designed to address today’s complex clinical supply challenges, from clinical supply management and forecasting, comparator and reference product sourcing, primary and secondary packaging, labelling, clinical storage from controlled room temperature to cryogenic, global cold chain distribution, and clinical returns and destruction.

	Speciality handling services are available for temperature, light and oxygen sensitive products, DEA Schedule I-V controlled drug substances and potent/cytotoxic products.

	Catalent. More products. Better treatments. Reliably supplied

In today’s challenging environment, every clinical study is different and changes can occur during project development which require unique, responsive solutions. Catalent offers flexible services designed to keep studies moving.